BMSSC
MRTX

B. Metzler seel. Sohn & Co’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,302
Closed -$436K – 781
2022
Q1 		$436K Buy
+5,302
New +$436K 0.01% 626